Related references
Note: Only part of the references are listed.Monocyte Count as a Prognostic Biomarker in Patients with Idiopathic Pulmonary Fibrosis
Michael Kreuter et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)
Multi-Modal Characterization of Monocytes in Idiopathic Pulmonary Fibrosis Reveals a Primed Type I Interferon Immune Phenotype
Emily Fraser et al.
FRONTIERS IN IMMUNOLOGY (2021)
Monocyte and neutrophil levels are potentially linked to progression to IPF for patients with indeterminate UIP CT pattern
Andrew Achaiah et al.
BMJ OPEN RESPIRATORY RESEARCH (2021)
The Roles of Immune Cells in the Pathogenesis of Fibrosis
Enyu Huang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The association between white blood cell count and outcomes in patients with idiopathic pulmonary fibrosis
Steven D. Nathan et al.
RESPIRATORY MEDICINE (2020)
Blood Cell Count Derived Inflammation Indexes in Patients with Idiopathic Pulmonary Fibrosis
Angelo Zinellu et al.
LUNG (2020)
Increased monocyte count as a cellular biomarker for poor outcomes in fibrotic diseases: a retrospective, multicentre cohort study
Madeleine K. D. Scott et al.
LANCET RESPIRATORY MEDICINE (2019)
Inflammation and immunity in IPF pathogenesis and treatment
P. Heukels et al.
RESPIRATORY MEDICINE (2019)
Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper
David A. Lynch et al.
LANCET RESPIRATORY MEDICINE (2018)
Diagnosis of Idiopathic Pulmonary Fibrosis An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis
Omkar Desai et al.
FRONTIERS IN MEDICINE (2018)
Idiopathic pulmonary fibrosis
Luca Richeldi et al.
LANCET (2017)
A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy
Qi Qi et al.
CANCER (2016)
Neutrophil elastase promotes myofibroblast differentiation in lung fibrosis
Alyssa D. Gregory et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2015)
Natural history of idiopathic pulmonary fibrosis
Hyun Joo Kim et al.
RESPIRATORY MEDICINE (2015)
Inflammatory leukocyte phenotypes correlate with disease progression in idiopathic pulmonary fibrosis
Bethany B. Moore et al.
FRONTIERS IN MEDICINE (2014)
A Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis
Brett Ley et al.
ANNALS OF INTERNAL MEDICINE (2012)
Forced Vital Capacity in Patients with Idiopathic Pulmonary Fibrosis Test Properties and Minimal Clinically Important Difference
Roland M. du Bois et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
An Official ATS/ERSARS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Baseline BAL neutrophilia predicts early mortality in idiopathic pulmonary fibrosis
Brent W. Kinder et al.
CHEST (2008)
Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention
BK Duffy et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Neutrophils and immunity: challenges and opportunities
C Nathan
NATURE REVIEWS IMMUNOLOGY (2006)
Idiopathic pulmonary fibrosis - A composite physiologic index derived from disease extent observed by computed tomography
AU Wells et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Share Paper
